175 related articles for article (PubMed ID: 2169047)
1. Effects of androgen and antiandrogen treatment on canine prostatic arginine esterase.
Juniewicz PE; Barbolt TA; Egy MA; Frenette G; Dube JY; Tremblay RR
Prostate; 1990; 17(2):101-11. PubMed ID: 2169047
[TBL] [Abstract][Full Text] [Related]
2. Effect of combination treatment with zanoterone (WIN 49596), a steroidal androgen receptor antagonist, and finasteride (MK-906), a steroidal 5 alpha-reductase inhibitor, on the prostate and testes of beagle dogs.
Juniewicz PE; Hoekstra SJ; Lemp BM; Barbolt TA; Devin JA; Gauthier E; Frenette G; Dube JY; Tremblay RR
Endocrinology; 1993 Aug; 133(2):904-13. PubMed ID: 8393778
[TBL] [Abstract][Full Text] [Related]
3. The effect of the steroidal androgen receptor antagonist, Win 49,596, on the prostate and testis of beagle dogs.
Juniewicz PE; McCarthy M; Lemp BM; Barbolt TA; Shaw C; Hollenbaugh DM; Winneker RC; Reel JR; Batzold FH
Endocrinology; 1990 May; 126(5):2625-34. PubMed ID: 1691701
[TBL] [Abstract][Full Text] [Related]
4. Effect of the steroidal androgen receptor antagonist Win 49,596 on steroid-induced benign prostatic hyperplasia in the castrate beagle dog.
Juniewicz PE; Lemp BM; Barbolt TA; LaBrie TK; McCarthy M; Reel JR; Batzold FH
Prostate; 1990; 16(1):1-14. PubMed ID: 1689481
[TBL] [Abstract][Full Text] [Related]
5. Dose-dependent hormonal induction of benign prostatic hyperplasia (BPH) in castrated dogs.
Juniewicz PE; Lemp BM; Barbolt TA; LaBrie TK; Batzold FH; Reel JR
Prostate; 1989; 14(4):341-52. PubMed ID: 2473460
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Win 49,596, a novel steroidal androgen receptor antagonist, in animal models of prostate cancer.
Juniewicz PE; Fetrow N; Marinelli J; Wolf M; Young E; Lamb J; Isaacs JT
Prostate; 1991; 18(2):105-15. PubMed ID: 2006117
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of the 5 alpha-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies.
Imperato-McGinley J; Sanchez RS; Spencer JR; Yee B; Vaughan ED
Endocrinology; 1992 Sep; 131(3):1149-56. PubMed ID: 1324152
[TBL] [Abstract][Full Text] [Related]
8. Sequential androgen blockade: a biological study in the inhibition of prostatic growth.
Fleshner NE; Trachtenberg J
J Urol; 1992 Dec; 148(6):1928-31. PubMed ID: 1331549
[TBL] [Abstract][Full Text] [Related]
9. Endocrine profile of Win 49596 in the rat: a novel androgen receptor antagonist.
Snyder BW; Winneker RC; Batzold FH
J Steroid Biochem; 1989 Dec; 33(6):1127-32. PubMed ID: 2615357
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the pharmacological effects of a novel selective androgen receptor modulator, the 5alpha-reductase inhibitor finasteride, and the antiandrogen hydroxyflutamide in intact rats: new approach for benign prostate hyperplasia.
Gao W; Kearbey JD; Nair VA; Chung K; Parlow AF; Miller DD; Dalton JT
Endocrinology; 2004 Dec; 145(12):5420-8. PubMed ID: 15308613
[TBL] [Abstract][Full Text] [Related]
11. The preclinical development of bicalutamide: pharmacodynamics and mechanism of action.
Furr BJ; Tucker H
Urology; 1996 Jan; 47(1A Suppl):13-25; discussion 29-32. PubMed ID: 8560673
[TBL] [Abstract][Full Text] [Related]
12. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
Trachtenberg J; Hicks LL; Walsh PC
J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
[TBL] [Abstract][Full Text] [Related]
13. Ultrastructural and biochemical expressions of divergent differentiation in prostates of castrated dogs treated with estrogen and androgen.
Merk FB; Ofner P; Kwan PW; Leav I; Vena RL
Lab Invest; 1982 Nov; 47(5):437-50. PubMed ID: 6182388
[TBL] [Abstract][Full Text] [Related]
14. Hormonal and morphologic evaluation of the effects of antiandrogens on the blood supply of the rat prostate.
Shibata Y; Ono Y; Kashiwagi B; Suzuki K; Fukabori Y; Honma S; Yamanaka H
Urology; 2003 Nov; 62(5):942-6. PubMed ID: 14624931
[TBL] [Abstract][Full Text] [Related]
15. Effect of anti-androgen (TZP-4238) on steroid-induced canine prostatic hyperplasia. Light and electron microscopic investigations.
Murakoshi M; Inada R; Makino M; Suzuki M; Mieda M; Honma S; Yamanaka H
Acta Pathol Jpn; 1990 Dec; 40(12):871-9. PubMed ID: 1710865
[TBL] [Abstract][Full Text] [Related]
16. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
17. Multiple phenotypes of prostatic glandular cells in castrated dogs after individual or combined treatment with androgen and estrogen. Morphometric, ultrastructural, and cytochemical distinctions.
Merk FB; Warhol MJ; Kwan PW; Leav I; Alroy J; Ofner P; Pinkus GS
Lab Invest; 1986 Apr; 54(4):442-56. PubMed ID: 2421104
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural and quantitative immunohistochemical changes induced by nonsteroid antiandrogens on pituitary gonadotroph population of prepubertal male rats.
Cónsole GM; Jurado SB; Rulli SB; Calandra RS; Gómez Dumm CL
Cells Tissues Organs; 2001; 169(1):64-72. PubMed ID: 11340263
[TBL] [Abstract][Full Text] [Related]
19. Role of canine basal cells in postnatal prostatic development, induction of hyperplasia, and sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 Aug; 48(3):210-24. PubMed ID: 11494337
[TBL] [Abstract][Full Text] [Related]
20. Blockade of androstenedione-induced stimulation of androgen-sensitive parameters in the rat prostate by combination of Flutamide and 4-MA.
Martel C; Trudel C; Couet J; Labrie C; Bélanger A; Labrie F
Mol Cell Endocrinol; 1993 Feb; 91(1-2):43-9. PubMed ID: 8472853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
